Tolvaptan for Autosomal Dominant Polycystic Kidney Disease in Children: Why, Who, and When? : Clinical Journal of the American Society of Nephrology

Journal Logo

Editorial

Tolvaptan for Autosomal Dominant Polycystic Kidney Disease in Children: Why, Who, and When?

Hartung, Erum A.

Author Information
Clinical Journal of the American Society of Nephrology 18(1):p 11-13, January 2023. | DOI: 10.2215/CJN.0000000000000028
Copyright © 2023 by the American Society of Nephrology

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid